Stock listing

CMPX Stock Price, News, Filings & Events — Compass Therapeutics, Inc.

Selected listing: CMPX · NASDAQ · USD · US

This page tracks Compass Therapeutics, Inc.'s CMPX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CMPX:NASDAQ. CMPX:NASDAQ is the stock-level entry point for investors researching Compass Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Compass Therapeutics, Inc. (ticker: CMPX) is a public company operating in the American market, with a market capitalization of approximately $372.8 million. The company focuses on developing innovative therapies to address unmet medical needs. Compass Therapeutics is committed to advancing its research and development efforts in the biopharmaceutical sector.

CMPX:NASDAQUSDUSUpdated September 11, 2026
Compass Therapeutics, Inc. logo
Ticker
CMPX:NASDAQ
Asset type
Stock
Market cap
$360.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Compass Therapeutics, Inc. CMPX:NASDAQ stock context

This page tracks Compass Therapeutics, Inc.'s CMPX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CMPX:NASDAQ. CMPX:NASDAQ is the stock-level entry point for investors researching Compass Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Compass Therapeutics, Inc. (ticker: CMPX) is a public company operating in the American market, with a market capitalization of approximately $372.8 million. The company focuses on developing innovative therapies to address unmet medical needs. Compass Therapeutics is committed to advancing its research and development efforts in the biopharmaceutical sector.

Latest news from Compass Therapeutics, Inc.

All Compass Therapeutics, Inc. news →

Compass Therapeutics, Inc. earnings calls

Research Compass Therapeutics, Inc.

Alternate listings